$CAI

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 19, 4:30 PM ET

$CAISEC Form 4bearish

Brille Brian J · See Remarks at Caris Life Sciences, Inc. · 32d agono track record yet

Sold 400,000 @ $30.33 avg · $12,132,080 · 2026-09-17

Form 4: Brille Brian J sold CAI

Brille Brian J (See Remarks at Caris Life Sciences, Inc.) reported an open-market sale of 400,000 shares of CAI at an average $30.33, roughly $12,132,080, in a Form 4 filed 2026-09-17.

At post $30.92Now $30.71-0.7% since postedas of Oct 19, 4:30 PM ET

1d-3.0%

3d-3.0%

1w+4.4%

1m-1.2%

3m—

6m—

1y—

View filing on SEC.gov →

$CAISEC Form 4bearish

Spetzler David Baxley · President at Caris Life Sciences, Inc. · 45d agono track record yet

Sold 597,212 @ $24.84 avg · $14,834,107 · 2026-09-03

Form 4: Spetzler David Baxley sold CAI

Spetzler David Baxley (President at Caris Life Sciences, Inc.) reported an open-market sale of 597,212 shares of CAI at an average $24.84, roughly $14,834,107, in a Form 4 filed 2026-09-04.

At post $25.07Now $30.71+22.5% since postedas of Oct 19, 4:30 PM ET

1d—

3d—

1w-2.9%

1m+12.9%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.